These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 6307248)

  • 41. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers.
    Witter RL; Sharma JM; Lee LF; Opitz HM; Henry CW
    Avian Dis; 1984; 28(1):44-60. PubMed ID: 6326743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.
    Lee LF; Liu X; Witter RL
    J Immunol; 1983 Feb; 130(2):1003-6. PubMed ID: 6184394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A recombinant fowlpox virus vaccine expressing glycoprotein B gene from CVI988/Rispens strain of MDV: protection studies in different chickens.
    Liu X; Peng D; Wu X; Xing L; Zhang R
    Acta Virol; 1999; 43(2-3):201-4. PubMed ID: 10696446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccine-induced host responses against very virulent Marek's disease virus infection in the lungs of chickens.
    Haq K; Abdul-Careem MF; Shanmuganthan S; Thanthrige-Don N; Read LR; Sharif S
    Vaccine; 2010 Aug; 28(34):5565-72. PubMed ID: 20600510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody titers to infectious bursal disease virus in broiler chicks after vaccination at one day of age with infectious bursal disease virus and Marek's disease virus.
    Knoblich HV; Sommer SE; Jackwood DJ
    Avian Dis; 2000; 44(4):874-84. PubMed ID: 11195642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines.
    King D; Page D; Schat KA; Calnek BW
    Avian Dis; 1981; 25(1):74-81. PubMed ID: 6268052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular evaluation of responses to vaccination and challenge by Marek's disease viruses.
    Tan J; Cooke J; Clarke N; Tannock GA
    Avian Pathol; 2007 Oct; 36(5):351-9. PubMed ID: 17899458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens.
    Darteil R; Bublot M; Laplace E; Bouquet JF; Audonnet JC; Rivière M
    Virology; 1995 Aug; 211(2):481-90. PubMed ID: 7645252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marek's disease: a model for protection against herpesvirus-induced tumours.
    Schat KA
    Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased virulence of Marek's disease virus field isolates.
    Witter RL
    Avian Dis; 1997; 41(1):149-63. PubMed ID: 9087332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines.
    Bacon LD; Witter RL
    Avian Dis; 1994; 38(1):65-71. PubMed ID: 8002902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Field safety and efficacy of in ovo administration of HVT + SB-1 bivalent Marek's disease vaccine in commercial broilers.
    Sarma G; Greer W; Gildersleeve RP; Murray DL; Miles AM
    Avian Dis; 1995; 39(2):211-7. PubMed ID: 7677641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
    Gagic M; St Hill CA; Sharma JM
    Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Marek's disease vaccine breaks: differences in viremia of vaccinated chickens between those with and without Marek's disease.
    Cho BR
    Avian Dis; 1976; 20(3):496-503. PubMed ID: 183650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attenuated revertant serotype 1 Marek's disease viruses: safety and protective efficacy.
    Witter RL
    Avian Dis; 1991; 35(4):877-91. PubMed ID: 1664721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chicken embryonal vaccination with avian infectious bronchitis virus.
    Wakenell PS; Sharma JM
    Am J Vet Res; 1986 Apr; 47(4):933-8. PubMed ID: 3008613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
    Islam T; Walkden Brown SW; Renz KG; Fakhrul Islam AF; Ralapanawe S
    Avian Pathol; 2013 Dec; 42(6):516-26. PubMed ID: 24098951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative viral, immunologic, and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch.
    Sharma JM; Lee LF; Wakenell PS
    Am J Vet Res; 1984 Aug; 45(8):1619-23. PubMed ID: 6089624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.